Newly-created Chief Technology Officer role marks a new chapter for bit.bio as the company expands its leadership team and technology portfolio The ioScreen platform enables pharmaceutical, biotechnology and in silico companies to access industrial-scale CRISPR screening in human stem cell-derived models without building specialist in-house capabilities Service gives researchers a more physiologically relevant way to […]

Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing and streamline development of safer, more effective medicine Delivered in partnership with the National Centre for the Replacement, Refinement and Reduction […]

New 3D Ready™ Cardioid Supplement Kits combine advanced cardiac organoid biology and automated workflows to help researchers generate more reproducible, scalable cardiac models for drug discovery and safety assessment SAN JOSE, Calif., and VIENNA – Molecular Devices, LLC., a Danaher company and a leading provider of high-performance life science solutions, and HeartBeat.bio today announced the upcoming availability of the […]

MIMETAS’ unique organ-on-a-chip and human tissue models complement Bruker’s multiomics, NMR, spatial biology and preclinical imaging solutions LEIDEN, The Netherlands — Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker’s post-genomic solutions […]

Therapeutic and diagnostic developers gain flexibility, speed, and scalability to advance custom formulations from preclinical research to manufacturing for clinical trials, with a reviewed quote returned in under three business days HOLLISTER, Calif. — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, […]

OBERKOCHEN, Germany — Revolune today announced a partnership with Propath UK to expand customer access to Revolune’s multiplex immunofluorescence workflow. Under the partnership, Propath UK will join Revolune’s Service Provider Program, supporting customers who want to access Revolune-powered multiplex staining workflows through an experienced service laboratory. The partnership is designed to help researchers and translational […]

Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]

Collaboration, coordinated through NCSTAR at QIMR Berghofer, gives Queensland researchers a pathway to trial and validate MGI’s integrated DCSP framework — spanning DNA genomics, cell omics, spatial omics and proteomics — locally, fast-tracking their translation into real-world research and future clinical applications. Brisbane, Australia — MGI Australia, the local Australia and New Zealand team of MGI Tech Co., Ltd. (MGI), […]

Stockholm-based service provider adds Evercode to its single cell sequencing offerings SEATTLE — Parse Biosciences, the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced that Xpress Genomics has joined its Certified Service Provider (CSP) program, becoming the first in the Nordic region. The Stockholm-based company will offer Parse’s Evercode single cell […]

Agreement marks the start of Eppendorf’s planned manufacturing facility in Penang Eppendorf will invest EUR 40 million in the site, with production expected to start in 2028 New facility will produce selected products of the Centrifuges & Instruments portfolio for global laboratory markets Penang, Malaysia – Eppendorf has signed an agreement for a new production […]